Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04359069

Optimal Duration of Urinary Catheterization After Total Mesorectal Excision A Prospective Randomized Trial Comparing Catheter Removal on Postoperative Day 1 Versus Day 3

Led by University of Southern California · Updated on 2026-02-05

176

Participants Needed

2

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the optimal duration of urinary catheter use after pelvic colorectal surgery, specifically total mesorectal excision (TME). This study aims to compare whether removing the catheter on the first day after surgery is as safe as the current standard of removing it on the third day. The goal is to reduce complications like urinary retention, urinary tract infections, and longer hospital stays, while improving recovery. This is a prospective, randomized, non-inferiority trial conducted by the University of Southern California. Participants undergoing TME will be randomly assigned to two groups: one with catheter removal on postoperative day 1 (experimental group) and the other with removal on day 3 (control group). Catheter removal is scheduled at 9 AM on the assigned days. The study involves standard care during and after surgery, including intravenous fluids and monitoring. The main comparison focuses on urinary retention rates, while secondary measures include urinary tract infections and hospital stay length. During the hospital stay, researchers will monitor urinary retention by checking if patients can urinate within 6 hours after catheter removal and using bladder scans if needed. Urinary tract infections will be diagnosed based on symptoms and urine cultures, treated as standard. Data on patient demographics, surgery details, and outcomes will be collected until discharge, which marks the study endpoint. The average hospital stay is about 4 days, and no follow-up is required after discharge.

CONDITIONS

Brief Title

Duration of Urinary Catheterization

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Elective total mesorectal excision procedures, including low anterior resection, abdominoperineal resection for rectal cancer, and proctectomy for inflammatory bowel disease
  • All surgical approaches included: open, laparoscopic, and robotic
  • Patients who received neoadjuvant chemotherapy and/or radiation
  • Age 18 years or older
  • American Society of Anesthesiologists (ASA) class I to III
  • Ability to understand and willing to sign informed consent
Not Eligible

You will not qualify if you...

  • Emergent or urgent surgery
  • Total mesorectal excision combined with other major surgeries on the same day
  • Genitourinary tract injury during surgery
  • History of urinary retention after previous procedures or catheter removal
  • Untreated history of urinary retention
  • Need for prolonged or replacement urinary catheter for reasons other than urinary retention
  • History of neurogenic bladder
  • Chronic indwelling Foley or suprapubic catheter
  • History of cystectomy or surgically created urinary conduit
  • Patients under 18 years old
  • Vulnerable patients unable or unwilling to provide informed consent, including incarcerated individuals

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (perioperative)

Surgery and Immediate Post-operative Care

Duration - Day of surgery to postoperative day 1 or 3 (depending on group assignment)

Participants undergo total mesorectal excision surgery and receive urinary catheterization during and after surgery as part of standard care.

Hospital stay with daily monitoring

Treatment

Duration - Up to 3 days post-surgery until catheter removal and monitoring

Participants have their urinary catheter removed either on postoperative day 1 (experimental group) or postoperative day 3 (control group). They are monitored for urinary retention and urinary tract infections.

Hospital stay with daily assessments

Post-operative Follow-up

Duration - Until hospital discharge (average 4 days post-surgery)

Participants are observed in the hospital until discharge to monitor for urinary retention, urinary tract infections, and length of hospital stay.

Daily hospital visits and assessments until discharge

Trial Site Locations

Total: 2 locations

1

Keck Hospital of USC

Los Angeles, California, United States, 90033

Actively Recruiting

2

Los Angeles County Hospital (LAC/USC)

Los Angeles, California, United States, 90033

Actively Recruiting

Loading map...

Research Team

S

Sarah Koller, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

A Safety and Effectiveness Prospective Blinded Clinical Stud...

Colorectal Surgery

Actively Recruiting

13 locations

Anastomotic Leakage Prevention by Endovascular Stenting of t...

Mesenteric Vascular Disease

Actively Recruiting

10 locations

Ultrasound-Guided Bilateral Erector Spinae Plane Block Versu...

Bilateral Erector Spinae Plane Block

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Early Removal of the Urinary Catheter After Total or Tumor-Specific Mesorectal Excision for Rectal Cancer Is Safe.

Byung Eun Yoo, Bong Hyeon Kye, Hyung Jin Kim...

https://pubmed.ncbi.nlm.nih.gov/26200683

Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.

Devin N Patel, Seth I Felder, Michael Luu...

https://pubmed.ncbi.nlm.nih.gov/30192326

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien

https://pubmed.ncbi.nlm.nih.gov/15273542